Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
ENGN

Price
10.64
Stock movement up
+1.30 (13.92%)
Company name
enGene Holdings Inc. Common Stock
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
712.72M
Ent value
716.32M
Price/Sales
-
Price/Book
4.25
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return (CAGR)
52.47%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2026-01-22

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

ENGN does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book4.25
EV to Sales-

FINANCIALS

Per share

Loading...
Per share data
Current share count66.98M
EPS (TTM)-1.28
FCF per share (TTM)-1.96

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)-509.00K
Operating income (TTM)-9.02M
Net income (TTM)-65.67M
EPS (TTM)-1.28
EPS (1y forward)-2.02

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash50.15M
Net receivables2.23M
Total current assets201.39M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment12.30M
Total assets221.47M
Accounts payable6.69M
Short/Current long term debt31.80M
Total current liabilities31.98M
Total liabilities53.76M
Shareholder's equity167.71M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-99.24M
Capital expenditures (TTM)1.49M
Free cash flow (TTM)-100.72M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-39.16%
Return on Assets-29.65%
Return on Invested Capital-34.02%
Cash Return on Invested Capital-52.18%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open9.50
Daily high10.88
Daily low9.34
Daily Volume1.08M
All-time high28.44
1y analyst estimate23.50
Beta-0.27
EPS (TTM)-1.28
Dividend per share0.00
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
ENGNS&P500
Current price drop from All-time high-62.59%-0.89%
Highest price drop-89.99%-19.00%
Date of highest drop13 May 20258 Apr 2025
Avg drop from high-78.25%-2.49%
Avg time to new high-6 days
Max time to new high324 days89 days

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ENGN (enGene Holdings Inc. Common Stock) company logo
Marketcap
712.72M
Marketcap category
Small-cap
Description
enGene Holdings Inc., through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada. The company develops genetic medicines to help patients suffering from bladder cancer. Its lead product candidate is detalimogene voraplasmid, a monotherapy for the treatment of non-muscle invasive bladder cancer (NMIBC). Its pipeline includes LEGEND, which is in Phase 2. enGene Holdings Inc. is based in Montreal, Canada.
Employees
81
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...